European Affairs


European Affairs

EHA represents hematology and hematologists in Europe. We strive to achieve more and better research funding opportunities, improve regulation, increase the availability of affordable medicines, and harmonize education and training of hematologists.

5 Positions of EHA


EHA increased its efforts to support research in hematology in Europe. These efforts include advocating for increased research funding and improved research regulations. As well as supporting the careers of excellent researchers in hematology through funding and education programs. Moreover EHA itself participates in selected European research projects, not doing the science, but offering a platform to collaborate and disseminate the results. Currently, EHA is involved as a partner organization in a Marie Sklodowska Curie Innovative Training Network – European Industrial Doctorate (EID) project called ‘PROFILE’. In this project, six Phd students are trained in the field of Thrombotic thrombocytopenic purpura (TTP).

All relevant information is now available through:

European Reference Networks (ERNs)

European reference networks (ERNs) for rare diseases should serve as research and knowledge centers, updating and contributing to the latest scientific findings, treating patients from other Member States and ensuring the availability of subsequent treatment facilities where necessary. The definition of ERN should also reflect the need for services and expertise to be distributed across the EU. Source: click here.

EHA endorses one network in hematology, comprising both malignant and non-malignant hematology, and will apply for one comprehensive ERN. 

For more information on European Reference Networks, click here.

Research Roadmap

EHA is proud to announce that The European Hematology Association Roadmap for European Hematology Research: A Consensus Document is now published.

  • Click here to read the full article on the Haematologica website
  • Click here to read the editorial on the Haematologica website
  • Click here to read the Press Release
  • Click here to read the editorial in Lancet Haematology March 2016
    Position of EHA on the Harmonization of Training and Education in Europe
    Position of EHA on Research Funding
    Position of EHA on Clinical Trials
    Position of EHA on Personalized Medicine